Top 3 features by frequency (%), irrespective of the first, second, or third position (preliminary data).
| Domain | Frequency in Top 3, n = 46* | Amsterdam, n = 14 | Vienna, n = 27 | PRP, n = 5 |
|---|---|---|---|---|
| Pain | 28 (61) | 5 (36) | 19 (70) | 4 (80) |
| Independence | 11 (24) | 2 (14) | 7 (26) | 2 (40) |
| Fatigue | 10 (22) | 2 (14) | 6 (22) | 2 (40) |
| Leisure/sports | 9 (20) | 4 (29) | 5 (19) | 0 (0) |
| Physical functioning | 7 (15) | 2 (14) | 4 (15) | 1 (20) |
| Being mobile | 6 (13) | 1 (7) | 5 (19) | 0 (0) |
| Social life | 6 (13) | 5 (36) | 1 (4) | 0 (0) |
| Ability to work | 6 (13) | 3 (21) | 3 (11) | 0 (0) |
| Swelling | 5 (11) | 1 (7) | 3 (11) | 1 (20) |
| Mood | 5 (11) | 0 (0) | 5 (19) | 0 (0) |
| Use of DMARD | 5 (11) | 2 (14) | 3 (11) | 0 (0) |
| Daily activities | 5 (11) | 1 (7) | 3 (11) | 1 (20) |
↵* Three respondents did not provide the top 3 features. DMARD: disease-modifying antirheumatic drugs; PRP: patient research partners.